Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia

被引:20
作者
Fadini, Gian Paolo [1 ]
Rigato, Mauro [1 ]
Tiengo, Antonio [1 ]
Avogaro, Angelo [1 ]
机构
[1] Univ Padua, Sch Med, Div Metab, Dept Clin & Expt Med, Padua, Italy
关键词
Diabetes; Hypoglycemia; Mortality; Morbidity; INSULIN-RESISTANCE; PREDICTION;
D O I
10.1016/j.diabres.2009.01.019
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims: Severe hypoglycemia can be dramatic in diabetic patients, but its long-term outcome is unknown. We aimed to describe clinical characteristics of type 2 diabetic patients hospitalized for iatrogenic hypoglycemia, and find predictors of long-term mortality, with a special regard to anti-hyperglycemic regimens. Methods: We retrospectively analyzed 126 episodes of severe hypoglycemia in type 2 diabetic patients. We collected data on the event (coma, pre-hospital fall, glucose level, duration of hypoglycemia), concomitant risk factors, diabetic complications and chronic comorbidities. We divided patients according to the use of insulin or oral agents (OHAs). Inhospital outcomes were acute coronary syndrome (ACS) and duration of hospitalization. We finally assessed long-term mortality. Results: Hypoglycemia due to OHA was associated with higher prevalence of coma and longer duration than hypoglycemia due to insulin. OHA use was also associated with a longer hospital stay, but no increase in the incidence of ACS. Overall mortality after a 2-year median follow-up was 42.1%. Despite the apparent worse presentation of hypoglycemic episodes associated with OHA use, this did not lead to an increased long-term mortality. Conclusions: Severe iatrogenic hypoglycemia in OHA-treated patients has a worse presentation, but is not associated with a higher long-term mortality than in insulin-treated patients. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:267 / 272
页数:6
相关论文
共 25 条
[1]
*AM DIAB ASS, 2008, ACC TRIAL QUEST ANSW
[2]
[Anonymous], 1996, DIABETES, V45, P1289
[3]
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial [J].
Bonds, Denise E. ;
Kurashige, Ella Mae ;
Bergenstal, Richard ;
Brillon, David ;
Domanski, Michael ;
Felicetta, James V. ;
Fonseca, Vivian A. ;
Hall, Kathleen ;
Hramiak, Irene ;
Miller, Michael E. ;
Osei, Kwame ;
Simons-Morton, Denise G. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) :80I-89I
[4]
Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care [J].
Brown, AF ;
Gross, AG ;
Gutierrez, PR ;
Jiang, LH ;
Shapiro, MF ;
Mangione, CM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (05) :665-670
[5]
Prediction of severe hypoglycemia [J].
Cox, Daniel J. ;
Gonder-Frederick, Linda ;
Ritterband, Lee ;
Clarke, William ;
Kovatchev, Boris P. .
DIABETES CARE, 2007, 30 (06) :1370-1373
[6]
Severe iatrogenic hypoglycemia in type 2 diabetes mellitus [J].
Cryer, Philip E. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (01) :4-5
[7]
Association of hypoglycemia and cardiac ischemia - A study based on continuous monitoring [J].
Desouza, C ;
Salazar, H ;
Cheong, B ;
Murgo, J ;
Fonseca, V .
DIABETES CARE, 2003, 26 (05) :1485-1489
[8]
Intensive glycemic control in the ACCORD and ADVANCE trials [J].
Dluhy, Robert G. ;
McMahon, Graham T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) :2630-2633
[9]
*EUR UN GER MED SO, CLIN GUID TYP 2 DIAB
[10]
Frier BM, 2002, INT J CLIN PRACT, P12